Questions and Answers
What is the generic name of Januvia?
What is the mechanism of action of Januvia?
Sitagliptin prolongs the action of GLP-1 and GIP, increases insulin production, and lowers glucagon secretion.
Januvia is indicated for the treatment of type 1 diabetes.
False
What serious safety concern is associated with taking Januvia?
Signup and view all the answers
What is a common administration route for Januvia?
Signup and view all the answers
What is the recommended dosing schedule for Januvia?
Signup and view all the answers
What effect does Januvia have on blood sugar levels in type 2 diabetes?
Signup and view all the answers
Are there differences in efficacy and safety of Januvia between elderly and younger patients?
Signup and view all the answers
What potential renal issue is associated with the use of Januvia?
Signup and view all the answers
What is an important risk associated with Januvia?
Signup and view all the answers
What side effects are commonly associated with Januvia?
Signup and view all the answers
Study Notes
Januvia Overview
- Generic name: Sitagliptin; belongs to the DPP-4 inhibitor class.
- Effective in lowering blood sugar levels for individuals with type 2 diabetes.
Efficacy and Indications
- Utilized as a treatment for type 2 diabetes in adults to manage blood sugar levels.
- Clinical trials have assessed long-term cardiovascular outcomes in patients with type 2 diabetes who have a history of cardiovascular disease.
Safety and Side Effects
- There is a risk of pancreatitis, potentially severe and life-threatening. Prior history of pancreatitis should be disclosed to a doctor before starting the medication.
- Possible renal issues reported, including acute renal failure, especially in patients with renal insufficiency or those on inappropriate dosages.
- Severe joint pain may occur in some users of DPP-4 inhibitors.
- Common side effects include headache, drowsiness, weakness, dizziness, confusion, irritability, hunger, tachycardia, sweating, and jitteriness.
Dosing and Administration
- Administered once daily and should be combined with diet and exercise.
- Can be taken with or without food.
Mechanism of Action
- Sitagliptin prolongs the action of incretin hormones (GLP-1 and GIP), enhancing insulin production and lowering glucagon secretion, resulting in decreased hepatic glucose production.
Hypoglycemia Risk
- Significant risk of hypoglycemia associated with sitagliptin usage.
Cost Considerations
- Typically offers the lowest branded co-pay options across various insurance plans.
Efficacy Across Demographics
- No significant differences in safety or efficacy observed between elderly patients (65+ years) and younger patients, though older individuals may exhibit greater sensitivity to the drug.
Renal Function Monitoring
- Prior assessment of renal function is important before starting treatment and should be monitored periodically, as renal function deterioration has been reported post-marketing.
Hepatic Efficacy
- Known to decrease hepatic glucose overproduction.
Head-to-Head Trials Insights
- Combining sitagliptin with sulfonylureas (like glimepiride) or insulin increased the risk of hypoglycemia and led to weight gain in patients.
Studying That Suits You
Use AI to generate personalized quizzes and flashcards to suit your learning preferences.
Description
This quiz covers the details of Januvia, a medication used to manage type 2 diabetes. It discusses its efficacy, indications for use, potential side effects, and important safety precautions that users should be aware of. Test your knowledge on this important diabetes treatment!
